Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Gossamer Bio Securities Fraud Lawsuit
Business class action

Gossamer Bio Securities Fraud Lawsuit

Analysis based on 7 articles · First reported May 01, 2026 · Last updated May 12, 2026

Sentiment
-60
Attention
4
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market is negatively impacted by the news of a class action lawsuit against Gossamer Bio, as it suggests potential financial liabilities and reputational damage for the company. Investors who purchased Gossamer Bio securities during the Class Period are encouraged to join the lawsuit to recover their losses.

Biotechnology Legal Services
Event Summary

The The Schall Law Firm has filed a class action lawsuit against Gossamer Bio for alleged violations of the Securities Exchange Act of 1934. The lawsuit claims that Gossamer Bio made false and misleading statements to the market between June 16, 2025, and February 20, 2026, concerning the design of its Phase 3 PROSERA study, particularly regarding placebo response controls. Investors who suffered losses during this period are encouraged to contact Brian Schall of the The Schall Law Firm to participate in the lawsuit.

Key Actions
100 The Schall Law Firm filed class action lawsuit Gossamer Bio
90 Gossamer Bio made false statements
Entities Involved
stock
Gossamer Bio
Gossamer Bio is facing a class action lawsuit for allegedly making false and misleading statements regarding its Phase 3 PROSERA study, which has caused investors to suffer damages.
Importance 100 Sentiment -70
priv
The Schall Law Firm
The The Schall Law Firm is representing investors in a class action lawsuit against Gossamer Bio, seeking to recover losses for shareholders.
Importance 80 Sentiment 50
per
Brian Schall
Brian Schall is an attorney at the The Schall Law Firm, encouraging investors to contact the firm regarding the class action lawsuit against Gossamer Bio.
Importance 60 Sentiment 40
govactor
United States — United States Securities and Exchange Commission
The class action lawsuit against Gossamer Bio is for violations of rules promulgated by the United States — United States Securities and Exchange Commission.
Importance 20 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.